| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |